What's Hot in 2024: AI in CNS Research

The integration of AI in CNS research is a pivotal shift toward a more innovative and patient-centric future

The AI-driven transformation of preclinical and clinical research will continue and accelerate into 2024, including in the neuroscience area. AI's integration helps in dissecting disease pathogenesis, discovering, modeling, and analyzing the effects of novel therapeutics, ultimately improving patient outcomes. AI enhances understanding of mechanisms, accelerates novel targets identification, and fuels advances in drug discovery for CNS disorders. It helps generate compounds with unique properties, such as improved specificity or bioavailability.

AI application in analytical assays, including digital image and video (e.g. behavioral) analysis, speeds up and refines safety and efficacy studies, reducing the costs and bench-to-bed time for new therapeutics. Further, AI assists clinicians in making faster and more accurate decisions. Integrating clinical data, lab results, symptoms, medical history, and imaging results, AI provides insights that complement clinical expertise. This supports more informed decision-making in lead development and clinical trials.

Overall, the integration of AI in CNS research marks a pivotal shift towards a more efficient, innovative, and patient-centric future.

-- Artem Shatillo, Research Leader, CNS Discovery, Charles River